Table 2

Order of events for all participants enrolled in the project

Research activity	Baseline assessment session week 0	CUE1+ device intervention weeks 1–12	Sham CUE1+ device intervention weeks 1–12	Continue regular life weeks 1–12	Follow-up assessment session week 13
Participant identification	X
PIS	X
Participant screening	X
Participant recruitment and allocation	X
Demographic characteristic	X
MDS-UPDRS III	X				X
FGA	X				X
TUG	X				X
TUG DT	X				X
BRAIN test	X				X
DFT test	X				X
PKG	X	X	X	X	X
Participant clinical diary	X				X
MDS-UPDRS I, II, IV	X				X
PDQ-39	X				X
HADS	X				X
ABC	X				X
PSQI	X				X
FSS	X				X
Experimental group	X	X		X	X
Control group	X		X	X	X

ABC, Activity-specific Balance Confidence; TUG DT, TUG with simultaneous performance of a secondary cognitive numeracy task; FGA, Functional Gait Assessment; FSS, Fatigue Severity Scale; HADS, Hospital Anxiety and Depression Scale; MDS-UPDRS, Movement Disorder Society sponsored revision of the Unified Parkinson’s Disease Rating Scale; MDS-UPDRS I, collects information on non-motor aspects of experiences of daily living; MDS-UPDRS II, collects information on motor aspects of experiences of daily living; MDS-UPDRS III, clinically examines motor signs; MDS-UPDRS IV, collects information on motor complications; PDQ-39, Parkinson’s Disease Questionnaire-39; PIS, Participant Information Sheet; PKG, Parkinson’s KinetiGragh wrist band watch; PSQI, Pittsburgh Sleep Quality Index; BRAIN test, Bradykinesia Akinesia Incoordination test; DFT test, Digital Finger Tapping test; TUG, Timed UP and Go.